HOME >> BIOLOGY >> NEWS
New proteomics research promises to revolutionize biomedical discovery

Montral, July 19 2007 Human cells function through the concerted action of thousands of proteins that control their growth and differentiation. Yet, the specific function of most human proteins remains either unknown or poorly characterized. Diseases being often due to aberrations in the function of key cellular proteins, numerous large-scale research initiatives have been launched internationally to crack the function of all human proteins. In a research article that will be published in the July 20th issue of the journal Molecular Cell, a research team led by Dr. Benoit Coulombe from the Institut de recherches cliniques de Montral (IRCM) describes a powerful proteomics approach that promises to have a profound impact on our current understanding of the human proteome and the function of its individual proteins.

In this work, we have taken advantage of an intrinsic property of proteins in order to develop a method that we use to infer a putative function to many previously uncharacterized proteins, said Dr. Coulombe who is very excited by his teams achievement and the future prospects these efforts hold. The unique property of proteins, exploited by this Montreal research team, is the fact that proteins rarely work alone, but rather assemble with other proteins into complexes to concertedly exert their function. The strategy of the IRCM researchers was basically to identify the interaction partners of many proteins of well-known function, using sophisticated proteomics procedures and computational algorithms they developed. The initial guess of the scientists was that proteins interacting together are likely to be partners in the same biological pathway and, consequently, to serve the same (or related) function(s). By systematically identifying the interaction partners of 32 human proteins known to exert specific functions in gene transcription and RNA processing, the Coulombe team has defined an intricate network of 805 high-confidence interactions
'"/>

Contact: Lucette Thriault
lucette.theriault@ircm.qc.ca
514-987-5535
Institut de recherches cliniques de Montreal
19-Jul-2007


Page: 1 2 3

Related biology news :

1. Lab-on-a-chip device from Berkeley Lab to speed proteomics research
2. Role for proteomics in identifying hematologic malignancies
3. An infectious agent of deception, exposed through proteomics
4. NIST and NCI to collaborate on proteomics assessment
5. Advanced genomics and proteomics improve the diagnosis and treatment of a deadly lung disease
6. New Columbia University center aims to advance next generation of genomics, proteomics research
7. Premature births from inflammation and infection rapidly detected by proteomics technology
8. Searle grant funds proteomics initiative
9. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
10. Saudi Arabias KAUST names WHOI first research partner
11. Multinational research: protecting ecology means understanding people, too

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. ... of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), ... Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, ...
(Date:7/1/2020)... Calif. (PRWEB) , ... July 01, 2020 , ... ... on building awareness and solutions for glioblastoma—the most common and aggressive adult brain ... Lisa Haile, JD, PhD. Senior Fellows are charged with supporting the organization’s initiatives ...
(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions ... data services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: ... hospitalized patients with severe COVID-19. This is the first study of an XPO1 ...
Breaking Biology News(10 mins):
(Date:7/10/2020)... , ... July 08, 2020 , ... ... and products, announces a significant expansion of laboratory operations through its COVID-19 ... agencies implementing testing programs. , Bode-CARES provides a turnkey solution ...
(Date:7/10/2020)... ... July 09, 2020 , ... In most research ... to suppress pigment formation in zebrafish embryos, maintaining optical transparency to facilitate microscopic ... MA has been using the zebrafish model to investigate the causes of leukaemia ...
(Date:7/7/2020)... ... ... R3 International is now offering stem cell therapy for Alzheimers dementia in ... the patient's condition, treatment may be offered IV, intrathecal or with a combination. , ... dementia, and the incidence continues to increase as individuals live longer. There is no ...
(Date:7/1/2020)... ... June 29, 2020 , ... MedShift , ... in 2020, despite many obstacles created as a result of COVID-19. As a ... its partnered medical practices and medical manufacturers by expanding access to device offerings, ...
Breaking Biology Technology:
Cached News: